GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Additional Paid-In Capital

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Additional Paid-In Capital : ¥754 Mil(As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Additional Paid-In Capital?


Shandong Xinhua Pharmaceutical Co's quarterly additional paid-in capital declined from Jun. 2023 (¥754 Mil) to Sep. 2023 (¥0 Mil) but then increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥754 Mil).

Shandong Xinhua Pharmaceutical Co's annual additional paid-in capital increased from Dec. 2021 (¥484 Mil) to Dec. 2022 (¥724 Mil) and increased from Dec. 2022 (¥724 Mil) to Dec. 2023 (¥754 Mil).


Shandong Xinhua Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Additional Paid-In Capital Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 451.74 450.35 484.39 724.10 753.83

Shandong Xinhua Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 724.10 - 753.83 - 753.83

Shandong Xinhua Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Shandong Xinhua Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Xinhua Pharmaceutical Co (SZSE:000756) Business Description

Traded in Other Exchanges
Address
No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (SZSE:000756) Headlines

No Headlines